business

J. Edward Moreno1/31/25

AbbVie climbs on new immunology drug sales

Pharmaceutical company Abbvie’s share price rose in early trading after it reported better-than-expected earnings and upbeat 2025 guidance, with newer drugs delivering growth.

Overall, the company brought in $15 billion in revenue and $3.7 billion in profit in the last three months of 2024. It also set its 2025 guidance at $12.12 to $12.32 a share, compared to the $12.15 a share analysts polled by FactSet expected.

AbbVie’s largest segment, immunology, was able to keep its sales growing even after its patent for Humira, its blockbuster autoimmune drug, expired in 2023. The company’s newer immunology drugs, Skyrizi and Rinvoq, have offset the decline in sales of Humira. The patents for Skyrizi and Rinvoq expire in 2032 and 2033, respectively.

AbbVie Reports Full-Year and Fourth-Quarter 2024 Financial Results

AbbVie Reports Full-Year and Fourth-Quarter 2024 Financial Results

AbbVie’s largest segment, immunology, was able to keep its sales growing even after its patent for Humira, its blockbuster autoimmune drug, expired in 2023. The company’s newer immunology drugs, Skyrizi and Rinvoq, have offset the decline in sales of Humira. The patents for Skyrizi and Rinvoq expire in 2032 and 2033, respectively.

More Business

See all Business

Claire Yubin Oh

CART VS. GOLIATH

The economics of Instacart’s grocery delivery are pretty tight — AI might help, or hurt

AI proved to be a double-edged sword this week for Instacart, as the gains from a new ChatGPT integration were wiped out by an AI pricing allegation.

Instacart gift card display in Costco store, Queens, New York

A new pass to access American Airlines’ loyalty program will set you back $5,000

AA is doubling down on perks and partnerships, as the nonflying parts of the operation have become a billion-dollar business.

Silhouettes of passengers waiting at an airport

Air taxi companies have mastered a crucial piece of technology: The press release

In a “tongue-in-cheek infographic,” SMG Consulting calculated the flight hours to press release ratio of US air taxi companies.

Psychedelic flying car in rainbow sky 2D linear illustration concept

WHO’S FLYING THE PLANE?

Pilot shortages might only get worse for airlines in years to come

Even with the IATA projecting record sector profits, more pilots reaching retirement age could cause turbulence.

Cockpit Lufthansa Airbus airplane

Max Knoblauch12/9/25

US plane maker Boeing delivered 44 jets in November, marking a 17% dip from October but a drastic recovery from its 13 deliveries in the same month last year amid its machinists’ strike.

Boeing, which closed its $4.7 billion acquisition of key supplier Spirit AeroSystems on Monday, has delivered 537 jets year to date in 2025, significantly ahead of the 348 it delivered last year. Earlier this month, the company said its recovery was “in full force” and it expects positive free cash flow in 2026.

European rival Airbus expanded its annual delivery lead in the month, handing 72 jets over to customers. The manufacturer has made 657 deliveries on the year so far, but recently cut its annual delivery target to 790 from 820 due to quality issues.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.

©2025 Sherwood Media, LLC